VACCINE AGAINST STREPTOCOCCUS AGALACTIAE INFECTION USING NATIVE OR RECOMBINANT S. AGALACTIAE GLYCERALDHEYDE-3-PHOSPHATE DEHYDROGENASE (GAPDH) AS A TARGET ANTIGEN

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090269826A1
SERIAL NO

12282749

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

infection. Vaccination is used as a preventive approach and is administered by intravenous and/or intradermic and/or subcutaneous and/or mucosal route. Therefore, the invention field is in the area of the pharmaceutical industry.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSIDADE DO PORTO4099-002 PORTO

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ferreira, Da Silva Paula Maria das Neves Maia , PT 1 0
Nascimento, Baptista Marina de Barros Algés , PT 1 0
Rua, Vilanova Manuel João Couto (s. Miguel) , PT 2 0
Tavares, Gomes Maria Delfina da Conceição Porto , PT 1 0
Trieu-Cuot, Patrick Fontenay Aux Roses , FR 5 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation